Dimeric Sialic Acid Derivatives for Siglec Binding
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current Siglec ligands, such as monomeric and polymeric sialic acid derivatives, face limitations in affinity, selectivity, pharmacological tolerance, and stability, particularly for Siglec-2 (CD22), and have undefined and non-uniform sizes and compositions, which affect their therapeutic efficacy.
Innovation Solution
Development of dimeric sialic acid derivatives with a nitrogen substitution at the 9-position, which exhibit enhanced affinity and specificity as Siglec ligands due to divalency and specific substitution, allowing for binding to two binding pockets simultaneously, and can be modified to form prodrugs without the need for cell cultures or enzymes.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If polymeric sialic acid derivatives are used as Siglec ligands, then affinity increases due to multiple binding pockets, but molecular size becomes very high and composition becomes non-uniform
Solution Approach 1:
The patent segments the polymeric structure into discrete dimeric units connected by defined linkers. Instead of using high molecular weight polymers with multiple repeating units, the invention employs dimers with specific linker structures (e.g., alkylene, arylene, or heteroarylene groups) that provide controlled spacing between sialic acid moieties while maintaining manageable molecular sizes and defined compositions.
Solution Approach 2:
The patent systematically varies parameters such as linker length, linker type, and substitution patterns on the sialic acid rings to optimize affinity while controlling molecular size. By changing these parameters in a controlled manner rather than using indiscriminate polymerization, the invention achieves high affinity with defined, lower molecular weight structures.
2Reliability
If polymeric sialic acid derivatives are used as Siglec ligands, then affinity increases due to multiple binding pockets, but composition becomes non-uniform and undefined
Solution Approach 1:
The invention divides the polymeric approach into discrete dimeric segments with precisely defined compositions. Each dimer contains exactly two sialic acid units connected by a specific linker structure, eliminating the compositional heterogeneity inherent in polymeric materials where chain lengths and branching patterns vary.
Solution Approach 2:
The patent employs systematic parameter control in the synthesis of dimeric structures, using well-defined coupling reactions and linker chemistries that produce uniform products. This approach allows for precise control over stoichiometry and structure, resulting in compositionally homogeneous ligands with reproducible properties.
3Manufacturing precision
If monomeric sialic acid derivatives are used as Siglec ligands, then structure is simple and well-defined, but affinity is insufficient for therapeutic efficacy
Solution Approach 1:
The patent merges two monomeric sialic acid units into a dimeric structure through defined linker connections. This combination allows the ligand to simultaneously engage multiple Siglec binding pockets, thereby increasing affinity while maintaining the structural precision and definability characteristic of monomeric compounds.
Solution Approach 2:
The invention transitions from one-dimensional monomeric structures to two-dimensional dimeric arrangements, where two sialic acid units are positioned in specific spatial relationships through the linker. This dimensional expansion enables simultaneous interaction with multiple binding sites on the Siglec protein, enhancing affinity without sacrificing structural definition.
4Reliability
If dimeric sialic acid derivatives with 9-position nitrogen substitution are developed, then affinity and stability increase, but production complexity increases compared to monomers
Solution Approach 1:
The patent employs systematic parameter optimization in the synthesis of dimeric structures, including the selection of specific protecting group strategies, coupling reagents, and purification conditions. These parameter choices are designed to streamline the production process while achieving the desired stability and affinity characteristics of the dimeric ligands.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The dimeric sialic acid derivatives demonstrate significantly increased affinity and stability as Siglec ligands, offering improved therapeutic potential with defined structures and simplified production processes, suitable for treating various diseases including autoimmune disorders and cancers.
Implementation Method 1
Through the combination of the divalency and of the substitution in the 9-position, an unexpectedly high affinity was obtained
Data Source
AI summary
Sialic acid derivatives of the formula (I)in which the symbols have the definitions stated in the description are suitable as medicaments, more particularly for diseases whose course is influenced by Siglec ligands.